Amiselimod (MT-1303), a Novel Sphingosine 1-Phosphate Receptor-1 Modulator, Potently Inhibits the Progression of Lupus Nephritis in Two Murine SLE Models

Amiselimod (MT-1303), a Novel Sphingosine 1-Phosphate Receptor-1 Modulator, Potently Inhibits the Progression of Lupus Nephritis in Two Murine SLE Models

Amiselimod (MT-1303) is a novel and selective sphingosine 1-phosphate receptor-1 (S1P1) modulator with a more favorable cardiac safety profile than other S1P1 receptor modulators. In this study, we evaluated the effects of MT-1303 on the progression of lupus nephritis in two well-known murine system...

Full description

Bibliographic Details
Main Authors: Kunio Sugahara, Yasuhiro Maeda, Kyoko Shimano, Mikako Murase, Sachiko Mochiduki, Kana Takemoto, Tetsuhiro Kakimoto, Hiroyuki Utsumi, Koichi Oshita, Hirotoshi Kataoka
Format: Article
Language:English
Published: Hindawi Limited 2019-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2019/5821589

Internet

http://dx.doi.org/10.1155/2019/5821589

Similar Items